Skip to main content

Month: April 2021

Bioventus to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021

DURHAM, N.C., April 12, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Wednesday, May 12, 2021. Management will host a conference call to discuss its financial results and provide a business update, with a question and answer session, at 5:00 p.m. Eastern Time on May 12, 2021. Those who would like to participate may dial 844-945-2085 (442-268-1266 for international callers) and provide access code 8976184. A live webcast of the call and any accompanying materials will also be provided on the investor relations section of the Company’s website at https://ir.bioventus.com/. The webcast will be archived on the Company’s website...

Continue reading

3D Systems Announces Date of First Quarter 2021 Financial Results

ROCK HILL, S.C., April 12, 2021 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) announced today it will release its financial results for the first quarter of 2021 and file its Form 10-Q after the U.S. stock markets close on Monday, May 10, 2021. The company will hold a conference call and simultaneous webcast to discuss these financial results on Tuesday, May 11, 2021, at 8:30 a.m. Eastern Time.First Quarter 2021 Results Conference Call  Date: Tuesday, May 11, 2021  Time: 8:30 a.m. Eastern Time  Listen via webcast: www.3dsystems.com/investor  Participate via telephone: 201-689-8345  The webcast replay will be available approximately two hours after the end of the conference call at www.3dsystems.com/investor.Forward-Looking StatementsCertain statements made in this release that are not statements of historical or...

Continue reading

Crinetics Pharmaceuticals Announces Closing of Common Stock Offering

SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that it has closed its previously announced underwritten follow-on offering of 4,562,044 shares of its common stock at a price to the public of $16.44 per share. The gross proceeds to Crinetics from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were approximately $75.0 million. Investors in the offering included Deep Track Capital, Bain Capital Life Sciences, and Driehaus Capital Management, with participation from other new and existing stockholders. Crinetics intends to use the net proceeds...

Continue reading

Berkeley Lights to Report First Quarter 2021 Financial Results on May 11, 2021

EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the first quarter 2021 before market open on Tuesday, May 11, 2021. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the Company’s website at: www.berkeleylights.com. The webcast will be archived and available for replay after the event. About Berkeley Lights Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform...

Continue reading

Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021

SEATTLE, April 12, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May 5, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About Adaptive BiotechnologiesAdaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the...

Continue reading

FormFactor Introduces Automated Cryogenic System to Accelerate Quantum Computing Development

LIVERMORE, Calif., April 12, 2021 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ:FORM), a leading semiconductor test and measurement supplier, today launched its first product for the emerging quantum computing market, the HPD IQ1000, a scanning SQUID (Superconducting Quantum Interference Device) microscope. With rapid scan speed and process automation, the IQ1000 is the first commercial product of its kind to enable unattended and high-throughput characterization of trapped magnetic flux in superconducting circuits. Device designers can now eliminate the guesswork involved in the design of resilient superconducting circuits, and significantly reduce development time by locating and capturing detrimental magnetic vortices to enhance device performance.    Device characterization is a requisite for the development of the established...

Continue reading

Churchill Downs Incorporated 2021 First Quarter Financial Results Conference Call Invitation

LOUISVILLE, Ky., April 12, 2021 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company will release first quarter 2021 financial results after the market closes on Wednesday, April 21, 2021, and host a related conference call to discuss the quarter on Thursday, April 22, 2021, at 9 a.m. ET. Investors and other interested parties may listen to the teleconference by accessing the online, real-time webcast of the call at http://ir.churchilldownsincorporated.com/events.cfm or by calling (877) 372-0878 and entering the conference ID number 6449063 at least 10 minutes before the appointed time. International callers should dial (253) 237-1169. An online replay of the call will be available at http://ir.churchilldownsincorporated.com/events.cfm by noon ET on Thursday, April 22, 2021. A...

Continue reading

BAB, Inc. Reports Results for 1st Quarter FY 2021

DEERFIELD, Ill., April 12, 2021 (GLOBE NEWSWIRE) — BAB, Inc. (OTCQB: BABB), announced its financial results for the first quarter ended February 28, 2021. For the quarter ended February 28, 2021, BAB had revenues of $723,000 and net income of $333,000, or earnings of $0.05 per share, versus revenues of $696,000 and net income of $43,000, or earnings of $0.01 per share for the quarter ended February 29, 2020. Net income for the quarter ended February 28, 2021 included loan forgiveness of $228,000. This was the Payroll Protection Program loan received May 1, 2020 with notice of forgiveness in full on December 9, 2020. Operating income for the first quarter 2021 was $137,000. Total operating expenses were $586,000 for the quarter ended February 28, 2021 versus $638,000 for February 29, 2020. For February 28, 2021 there was a $32,000...

Continue reading

Northrop Grumman and Intelsat Make History with Docking of Second Mission Extension Vehicle to Extend Life of Satellite

DULLES, Va., April 12, 2021 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) and the company’s wholly-owned subsidiary, SpaceLogistics LLC, have successfully completed the docking of the Mission Extension Vehicle-2 (MEV-2) to the Intelsat 10-02 (IS-10-02) commercial communications satellite to deliver life-extension services. The docking was completed at 1:34 p.m. EST. Northrop Grumman is the only provider of flight-proven life extension services for satellites, and this is the second time the company has docked two commercial spacecraft in orbit. The company’s MEV-1 made history when it successfully docked to the Intelsat 901 (IS-901) satellite in February 2020. Unlike MEV-1, which docked above the GEO orbit before moving IS-901 back into service, MEV-2 docked with IS-10-02 directly in its operational GEO orbital location. “Today’s...

Continue reading

goeasy Ltd. Announces Acquisition of LendCare for $320 Million and Concurrent $130 Million Bought Deal Equity Offering of Subscription Receipts

LendCare is one of Canada’s leading point-of-sale consumer financing providers Strategic acquisition accelerates growth through product and point-of-sale channel expansion Attractive valuation and synergies to assist in producing long-term return on equity of 25%+ High return business will contribute to history of compounding earnings growth at over 30% Transaction expected to be immediately accretive to adjusted earnings per share, increasing to ~10% in 2022 and ~15% in 2023NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MISSISSAUGA, Ontario, April 12, 2021 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX: GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services, announced today that it has entered into a definitive agreement to acquire...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.